These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19466421)

  • 1. Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study.
    Cinar M; Dinc A; Simsek I; Erdem H; Koc B; Pay S; Kilic S
    Rheumatol Int; 2010 Jan; 30(3):331-40. PubMed ID: 19466421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs in patients with stable ankylosing spondylitis receiving tumor necrosis factor inhibitor: continued vs withdrawn.
    Park JH; Kwon OC; Park MC
    Clin Rheumatol; 2020 Dec; 39(12):3669-3675. PubMed ID: 32447601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs in ankylosing spondylitis.
    Miceli-Richard C; Dougados M
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S65-6. PubMed ID: 12463450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.
    Song IH; Heldmann F; Rudwaleit M; Listing J; Appel H; Braun J; Sieper J
    Arthritis Rheum; 2010 May; 62(5):1290-7. PubMed ID: 20461780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) - an open-label randomized controlled multicenter trial.
    Proft F; Muche B; Listing J; Rios-Rodriguez V; Sieper J; Poddubnyy D
    BMJ Open; 2017 Jun; 7(6):e014591. PubMed ID: 28601821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study.
    Dougados M; Nguyen M; Caporal R; Legeais J; Bouxin-Sauzet A; Pellegri-Guegnault B; Gomeni C
    Scand J Rheumatol; 1994; 23(5):243-8. PubMed ID: 7973477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: results of a 12-week, prospective, open-label, pilot (METALL) study].
    Gaydukova IZ; Rebrov AP; Poddubnyi DA
    Ter Arkh; 2015; 87(5):47-52. PubMed ID: 26155618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
    Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
    Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    van der Heijde D; Baraliakos X; Gensler LS; Maksymowych WP; Tseluyko V; Nadashkevich O; Abi-Saab W; Tasset C; Meuleners L; Besuyen R; Hendrikx T; Mozaffarian N; Liu K; Greer JM; Deodhar A; Landewé R
    Lancet; 2018 Dec; 392(10162):2378-2387. PubMed ID: 30360970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
    Prince DS; McGuigan LE; McGirr EE
    Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
    Pham T; Landewé R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D
    Ann Rheum Dis; 2006 Dec; 65(12):1620-5. PubMed ID: 16464984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD005468. PubMed ID: 25887212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
    Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
    Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).
    Sieper J; Listing J; Poddubnyy D; Song IH; Hermann KG; Callhoff J; Syrbe U; Braun J; Rudwaleit M
    Ann Rheum Dis; 2016 Aug; 75(8):1438-43. PubMed ID: 26242443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
    Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).
    Poddubnyy D; Hermann KG; Callhoff J; Listing J; Sieper J
    Ann Rheum Dis; 2014 May; 73(5):817-23. PubMed ID: 24389297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.
    Hebeisen M; Neuenschwander R; Scherer A; Exer P; Weber U; Tamborrini G; Micheroli R; Wildi LM; Zufferey P; Nissen MJ; Villiger PM; Bernhard J; Finckh A; van der Horst-Bruinsma IE; Sieper J; Landewé R; van der Heijde D; Ciurea A;
    J Rheumatol; 2018 Apr; 45(4):506-512. PubMed ID: 29449504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial.
    Wang P; Li Y; Huang L; Yang J; Yang R; Deng W; Liang B; Dai L; Meng Q; Gao L; Chen X; Shen J; Tang Y; Zhang X; Hou J; Ye J; Chen K; Cai Z; Wu Y; Shen H
    Cell Transplant; 2014; 23(10):1293-303. PubMed ID: 23711393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
    Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
    Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.